Results 71 to 80 of about 1,317,378 (148)

5-year cumulative switching rates of antihypertensive drugs according to medication class.

open access: yes, 2013
5-year cumulative switching rates of antihypertensive drugs according to medication class.
Martin C. S. Wong (288769)   +10 more
core   +1 more source

Lipid Profile and Antihypertensive Drugs

open access: yesمجله كليه طب الكندي, 2009
Background: Hypertension and dyslipidemia are cardiovascular risk factors that commonly coexist . Objective : To evaluate the effects of ß - blocker (Atenolol) , ACE inhibitor (Captopril) calcium Channel blocker (Nefidipin ) and diuretics on serum lipid
Abdul-Khader A. Abdul-Khader
doaj  

Interactions between antihypertensive drugs and food [PDF]

open access: yes, 2012
Objective: A drug interaction is defined as any alteration, pharmacokinetics and/or pharmacodynamics, produced by different substances, other drug treatments, dietary factors and habits such as drinking and smoking.
Jáuregui-Lobera,I.   +1 more
core  

Metabolic effects of antihypertensive drugs.

open access: yes, 1995
UNLABELLED EFFECTS OF ANTIHYPERTENSIVE DRUGS ON METABOLISM: Numerous antihypertensive drugs have been reported to cause adverse metabolic effects such as glucose intolerance and abnormal lipid metabolism.
Vetter W   +3 more
core   +1 more source

Pattern analysis and variations in the utilization of antihypertensive drugs in Taiwan: a six-year study

open access: yes, 2014
BACKGROUND: In the last few years there have been changed in the pattern of consumption of antihypertensive drugs in other countries. Factors causing this variability include differences in the effectiveness of detection, guidelines for the management of
Huang, L. -Y.;Shau, W. -Y.;Chen, H. -C.;Su, S.;Yang, M. -C.;Yeh, H. -L.;Lai, M. -S.   +1 more
core  

Effect of ACE Inhibitors, ARBs, and Other Antihypertensive Drugs on Hypertensive Patients with COVID-19 Infection

open access: yesNovelty in Biomedicine
Background: To investigate differences in disease severity and outcomes among COVID-19 patients with a history of hypertension using angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and other antihypertensive drugs.
Seyedpouzhia Shojaei   +7 more
doaj   +1 more source

Predictors of non-persistence to antihypertensive drugs in first year after initiation.

open access: yes, 2019
Predictors of non-persistence to antihypertensive drugs in first year after initiation.
Sofa D. Alfian (4765800)   +3 more
core   +1 more source

Expenditure on and access to antidiabetic, antihypertensive and antilipidemic drugs, FY 2010–2012.

open access: yes, 2019
Expenditure on and access to antidiabetic, antihypertensive and antilipidemic drugs, FY 2010–2012.
Chulaporn Limwattananon (6383459)   +1 more
core   +1 more source

Immediate Prescription of Oral Antihypertensive Agents in Hypertensive Urgency Patients and the Risk of Revisits with Elevated Blood Pressure

open access: yesOpen Access Emergency Medicine, 2020
Pungkava Sricharoen, Aroonkamol Poungnil, Chaiyaporn Yuksen Department of Emergency Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Chaiyaporn YuksenDepartment of Emergency Medicine, Faculty of ...
Sricharoen P, Poungnil A, Yuksen C
doaj  

Use of oral antihypertensive medication preceding blood pressure elevation in hospitalized patients

open access: yesArquivos Brasileiros de Cardiologia, 2001
OBJECTIVE: To evaluate the frequency of oral antihypertensive medication preceding the increase in blood pressure in patients in a university hospital, the drug of choice, and the maintained use of antihypertensive medication.
Macedo Cristiano Ricardo Bastos de   +4 more
doaj  

Home - About - Disclaimer - Privacy